Main Management ETF Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-733
Closed -$571K 162
2025
Q2
$571K Buy
733
+12
+2% +$9.32K 0.02% 128
2025
Q1
$595K Buy
721
+9
+1% +$7.49K 0.03% 118
2024
Q4
$550K Sell
712
-64
-8% -$53K 0.02% 134
2024
Q3
$687K Buy
+776
New +$698K 0.03% 133

Other funds holding LLY

Main Management ETF Advisors's LLY Position: Q3 2025 in Review

Main Management ETF Advisors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 733 shares — an estimated $571K sold.

Main Management ETF Advisors first reported a position in LLY in Q3 2024 and held it in 4 quarters. The position peaked at $687K in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Main Management ETF Advisors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Main Management ETF Advisors sold 733 Eli Lilly shares in Q3 2025, an estimated $571K.
  • Main Management ETF Advisors first reported a position in Eli Lilly in Q3 2024 and held it in 4 quarters.
  • Main Management ETF Advisors's Eli Lilly position peaked at $687K in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Main Management ETF Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.